Zhendong Chen

机构：University of Cologne · ORCID：0000-0002-2035-635X

发表论文 134 篇 · 总被引 11850 次 · h-index 27

代表论文

• Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial (2024 · Nature Medicine · 被引 35)
• Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial (2024 · European Journal of Cancer · 被引 21)
• A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer (2024 · BMC Cancer · 被引 18)
• Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer (2024 · Cancer Immunology Immunotherapy · 被引 17)
• Generating 1.2 GHz, 38 fs stretched-pulse directly from a robust mode locked solid-state fiber laser (2024 · Optics Express · 被引 10)
• Cnicin promotes functional nerve regeneration (2024 · Phytomedicine · 被引 7)